Sonja Zweegman | EHA 2018 | The issue of frailty in MM
Stephanie Hill , Jun 17, 2018
Paola Neri | EHA 2018 | The basis for immunotherapy in Multiple Myeloma
Stephanie Hill , Jun 16, 2018
General MM, & 3 more
Niels Van de Donk | EHA 2018 | Immunotherapy in myeloma: why, when and how?
Stephanie Hill , Jun 15, 2018
ASCO 2018 | Updated results from the CRB-401 phase I study of bb2121 CAR T-cells
General MM, & 2 more
ASCO 2018 | What happened with pembrolizumab in MM clinical trials?
ASCO 2018 | Phase I trial of ruxolitinib, lenalidomide, and methylprednisolone for RRMM
Vincent Rajkumar | ASCO 2018 | Value & cost of myeloma therapy - we cannot afford it
Stephanie Hill , Jun 6, 2018
Philippe Moreau | ASCO 2018 | Critical trials in MM that could change clinical practice
Philippe Moreau , Jun 5, 2018